BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38436769)

  • 1. Immune profiling analysis of double-negative T cells in patients with systemic sclerosis.
    Zhang D; Alip M; Chen H; Wu D; Zhu H; Han Y; Yuan X; Feng X; Sun L; Wang D
    Clin Rheumatol; 2024 May; 43(5):1623-1634. PubMed ID: 38436769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis.
    Fox DA; Lundy SK; Whitfield ML; Berrocal V; Campbell P; Rasmussen S; Ohara R; Stinson A; Gurrea-Rubio M; Wiewiora E; Spino C; Bush E; Furst D; Pillai S; Khanna D
    Arthritis Res Ther; 2021 Jan; 23(1):10. PubMed ID: 33407866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
    Fleury M; Belkina AC; Proctor EA; Zammitti C; Simms RW; Lauffenburger DA; Snyder-Cappione JE; Lafyatis R; Dooms H
    Arthritis Rheumatol; 2018 Apr; 70(4):566-577. PubMed ID: 29245183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
    Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
    Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
    Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
    Front Immunol; 2018; 9():753. PubMed ID: 29706966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].
    Ma XB; Zhang XW; Jia RL; Gao Y; Liu HJ; Liu YF; Li YN
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):721-727. PubMed ID: 34393235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered B lymphocyte homeostasis and functions in systemic sclerosis.
    Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S
    Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis.
    Agarbati S; Benfaremo D; Viola N; Paolini C; Svegliati Baroni S; Funaro A; Moroncini G; Malavasi F; Gabrielli A
    Front Immunol; 2022; 13():1072462. PubMed ID: 36618427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Sclerosis Perturbs the Architecture of the Immunome.
    Paleja B; Low AHL; Kumar P; Saidin S; Lajam A; Nur Hazirah S; Chua C; Li Yun L; Albani S
    Front Immunol; 2020; 11():1602. PubMed ID: 32849542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.
    Liu X; Gao N; Li M; Xu D; Hou Y; Wang Q; Zhang G; Sun Q; Zhang H; Zeng X
    PLoS One; 2013; 8(6):e64531. PubMed ID: 23776439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
    Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
    Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin-Resident Effector Memory CD8
    Li G; Larregina AT; Domsic RT; Stolz DB; Medsger TA; Lafyatis R; Fuschiotti P
    J Invest Dermatol; 2017 May; 137(5):1042-1050. PubMed ID: 28012718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in peripheral T- and B-cell subsets in patients with systemic sclerosis.
    Wu J; Zhang X; Lin S; Wei Q; Lin Z; Jin O; Gu J
    Int J Rheum Dis; 2024 Apr; 27(4):e15145. PubMed ID: 38661314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
    Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
    Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
    Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
    Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
    Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients.
    Guggino G; Lo Pizzo M; Di Liberto D; Rizzo A; Cipriani P; Ruscitti P; Candore G; Gambino CM; Sireci G; Dieli F; Giacomelli R; Triolo G; Ciccia F
    Clin Exp Immunol; 2017 Nov; 190(2):208-216. PubMed ID: 28681919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.